林 茂徳

Medicine & Life Sciences

1. Laparoscopy 100%
2. Salpingo-oophorectomy 91%
3. Uterine Cervical Neoplasms 77%
4. Lymph Node Excision 76%
5. Trachelectomy 66%
6. Laparotomy 54%
7. Uterine Perforation 54%
8. Ureter 52%
9. Hysterectomy 49%
10. Ovarian Neoplasms 48%
11. Neoplasms 48%
12. Human papillomavirus 18 45%
13. Ovarian Cysts 45%
14. Insemination 45%
15. Carcinoma 44%
16. Female Genitalia 42%
17. Human papillomavirus 16 41%
18. Homeobox Genes 41%
19. Plastic Surgery 38%
20. Pelvic Inflammatory Disease 36%
21. Endometrial Neoplasms 36%
22. Ligaments 34%
23. Retrospective Studies 33%
24. Carcinoma in Situ 33%
25. Connective Tissue 33%
26. Genitalia 32%
27. In Situ Hybridization 32%
28. Endoscopy 31%
29. Multicenter Studies 30%
30. Barium 30%
31. Drainage 30%
32. Small Interfering RNA 29%
33. Anatomy 28%
34. Real-Time Polymerase Chain Reaction 27%
35. Human Genome 27%
36. Transcription Factors 26%
37. Radiography 25%
38. Laparoscopes 25%
39. Uterus 24%
40. Cohort Studies 24%
41. Tomography 24%
42. Urinary Bladder 23%
43. Magnetic Resonance Imaging 23%
44. Female Genital Diseases 22%
45. Hysteroscopy 22%
46. Umbilical Arteries 21%
47. Phenotype 21%
48. Ovarian Epithelial Carcinoma 20%
49. Injections 20%
50. Sensitivity and Specificity 19%